UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 206

Sortiert nach

Measuring the clinical response. What does it mean?

European journal of cancer (1990), 2002-09, Vol.38 (14), p.1817-1823

Therasse, P

2002

Link zum Volltext

Verfügbarkeit prüfen

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

European journal of cancer (1990), 2009-01, Vol.45 (2), p.228-247

2009

Link zum Volltext

Verfügbarkeit prüfen

RECIST revisited: A review of validation studies on tumour assessment

European journal of cancer (1990), 2006-05, Vol.42 (8), p.1031-1039

2006

Link zum Volltext

Verfügbarkeit prüfen

231 INVITED How to Submit a Good Application?

European journal of cancer (1990), 2011, Vol.47, p.S55-S55

Therasse, P

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of lymph nodes with RECIST 1.1

European journal of cancer (1990), 2009-01, Vol.45 (2), p.261-267

2009

Link zum Volltext

Verfügbarkeit prüfen

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)

Annals of oncology, 2016-10, Vol.27 (10), p.1947-1947

2016

Link zum Volltext

Verfügbarkeit prüfen

Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study

Journal of clinical oncology, 2003-03, Vol.21 (5), p.843-850

2003

Link zum Volltext

Verfügbarkeit prüfen

Health related quality of life outcomes in cancer clinical trials

European journal of cancer (1990), 2005-08, Vol.41 (12), p.1697-1709

2005

Link zum Volltext

Verfügbarkeit prüfen

Measuring Response in Solid Tumors: Unidimensional Versus Bidimensional Measurement

JNCI : Journal of the National Cancer Institute, 1999-03, Vol.91 (6), p.523-528

1999

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of response: new and standard criteria

Annals of oncology, 2002-01, Vol.13 (suppl-4), p.127-129

THERASSE, P

2002

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for the assessment of progression in randomised cancer treatment trials

European journal of cancer (1990), 2009-01, Vol.45 (2), p.281-289

2009

Link zum Volltext

Verfügbarkeit prüfen

Lessons learned from independent central review

European journal of cancer (1990), 2009-01, Vol.45 (2), p.268-274

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience

Journal of clinical oncology, 1998-01, Vol.16 (1), p.145-152

1998

Link zum Volltext

Verfügbarkeit prüfen

RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma

European journal of cancer (1990), 2005-07, Vol.41 (10), p.1426-1430

2005

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality of Life Parameters As Prognostic Factors in a Nonmetastatic Breast Cancer Population: An International Multicenter Study

Journal of clinical oncology, 2004-08, Vol.22 (16), p.3381-3388

2004

Link zum Volltext

Verfügbarkeit prüfen

3032A Activity and safety profile of lucitanib in patients with advanced thymic epithelial tumours

European journal of cancer (1990), 2015-09, Vol.51, p.S607-S607

2015

Link zum Volltext

Verfügbarkeit prüfen

Update in methodology and conduct of cancer clinical trials

European journal of cancer (1990), 2006-07, Vol.42 (10), p.1322-1330

2006

Link zum Volltext

Verfügbarkeit prüfen

TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network

European journal of cancer (1990), 2006-11, Vol.42 (16), p.2684-2691

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials

European Journal of Cancer, 2003-11, Vol.39 (17), p.2439-2449

2003

Link zum Volltext

Verfügbarkeit prüfen

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials

European journal of cancer (1990), 2003-02, Vol.39 (3), p.275-285

2003

Link zum Volltext

Verfügbarkeit prüfen

Quality assurance within EORTC: past, present and future

European journal of cancer (1990), 2002-03, Vol.38, p.151-151

Therasse, P

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

European journal of cancer (1990), 2003-02, Vol.39 (3), p.309-316

2003

Link zum Volltext

Verfügbarkeit prüfen

TuBaFrost 3: Regulatory and ethical issues on the exchange of residual tissue for research across Europe

European journal of cancer (1990), 2006-11, Vol.42 (17), p.2914-2923

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials design and treatment tailoring: General principles applied to breast cancer research

Critical reviews in oncology/hematology, 2006-08, Vol.59 (2), p.98-105

2006

Link zum Volltext

Verfügbarkeit prüfen

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

Annals of oncology, 2003-03, Vol.14 (3), p.406-413

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(164)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(105)
Science & Technology
(96)
Life Sciences & Biomedicine
(93)
Biological And Medical Sciences
(70)
Medical Sciences
(67)
Oncology
(60)
Female
(47)
Male
(33)
Middle Aged
(33)
Tumors
(32)
Pharmacology. Drug Treatments
(31)
Treatment Outcome
(27)
Aged
(26)
Adult
(23)
Europe
(21)
Radiology, Nuclear Medicine & Medical Imaging
(18)
Neoplasms - Pathology
(17)
Breast Neoplasms - Drug Therapy
(14)
Chemotherapy
(14)
Clinical Trials
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Measuring the clinical response. What does it mean?

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

RECIST revisited: A review of validation studies on tumour assessment

231 INVITED How to Submit a Good Application?

Evaluation of lymph nodes with RECIST 1.1

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)

Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study

Health related quality of life outcomes in cancer clinical trials

Measuring Response in Solid Tumors: Unidimensional Versus Bidimensional Measurement

Evaluation of response: new and standard criteria

Recommendations for the assessment of progression in randomised cancer treatment trials

Lessons learned from independent central review

Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience

RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma

Health-Related Quality of Life Parameters As Prognostic Factors in a Nonmetastatic Breast Cancer Population: An International Multicenter Study

3032A Activity and safety profile of lucitanib in patients with advanced thymic epithelial tumours

Update in methodology and conduct of cancer clinical trials

TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials

Quality assurance within EORTC: past, present and future

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

TuBaFrost 3: Regulatory and ethical issues on the exchange of residual tissue for research across Europe

Clinical trials design and treatment tailoring: General principles applied to breast cancer research

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

Suchergebnisse filtern